GELS (Gelteq) Dividend Payout Ratio: 0.00 (As of Jun. 2025)


GELS Gelteq Ltd GELS
10 GF Score
Price $0.65
! 4 Warning Signs
View Full Analysis

What is Gelteq Dividend Payout Ratio?

Gelteq GELS +2.16% 10 Dividend Payout Ratio is 0.00 as of Jun. 2025. GuruFocus rates GELS with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 444 Drug Manufacturers companies, Gelteq ranks worse than 225225% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Gelteq's Dividend Payout Ratio for the months ended in Jun. 2025 was 0.00.

The historical rank and industry rank for Gelteq's Dividend Payout Ratio or its related term are showing as below:


GELS's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.375
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-06-27), the Dividend Yield % of Gelteq is 0.00%.

Gelteq's Dividends per Share for the months ended in Jun. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Gelteq (NAS:GELS) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Gelteq Dividend Payout Ratio Related Terms


Gelteq Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Gelteq's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Dividend Payout Ratio Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividend Payout Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25
Dividend Payout Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

GELS vs INM, LVRLF, BUDZ: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gelteq's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gelteq Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gelteq's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Gelteq's Dividend Payout Ratio falls into.


GELS
10GF Score
Gelteq Ltd GELS
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gelteq Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Gelteq's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2025 )/ EPS without NRI (A: Jun. 2025 )
=0/ -0.487
=N/A

Gelteq's Dividend Payout Ratio for the quarter that ended in Jun. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2025 )/ EPS without NRI (Q: Jun. 2025 )
=0/ -0.226
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Gelteq (GELS) has a Dividend Payout Ratio of 0.00 as of Jun. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Gelteq and its competitors. According to the industry distribution chart, Gelteq ranks #999999 out of 444 companies in the Drug Manufacturers industry.
Is Gelteq's Dividend Payout Ratio too high?
Gelteq's current Dividend Payout Ratio is 0.00. Based on the distribution chart, Gelteq ranks #999999 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Gelteq has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Dividend Payout Ratio compare to INM and LVRLF?
According to the Drug Manufacturers industry distribution chart, Gelteq ranks #999999 out of 444 companies for Dividend Payout Ratio. This places Gelteq in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Gelteq and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gelteq's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Gelteq's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Gelteq (GELS), the current Dividend Payout Ratio is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
10GF Score

Get the complete analysis for GELS

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price